SAKK/Incyte HERo in Science Award
For the past ten years more women than men have graduated from medical school each year and still, women remain largely underrepresented in impactful clinical research positions. This award is aimed to support outstanding women to contribute to clinical cancer research in Switzerland, to promote scientific excellence, and fosters equity and innovation.
The award is endowed with CHF 30’000.- and should encourage the continuation of a clinical or translational research project.
Eligible Candidates
With this grant, we offer a funding program specifically for female researchers. The aim is to promote and support their projects and careers in cancer research. The eligible candidates are:
- Practicing female physician currently active in clinical and/or translational cancer research within Switzerland
- The minimum requirement is a research activity in Switzerland from January 1st to December 31st, 2025
- No age restrictions apply
Scope
The award is granted to a female researcher who is conducting a clinical or translational research project with a tangible improvement on patient management and/or outcomes in the field of oncology and hematologic malignancies.
Application
Applications must be written in English and contain the following information:
- Project proposal max. five pages including the rationale, methodology, feasibility, budget and potential impact
- Curriculum Vitae of the candidate
- Publication list of the candidate
-
- Publications may be primary research or review articles
- The candidate must be an author in all publications
- Publications must have been published in the period 2015-2025 in a peer-reviewed journal or must be accepted for publication in a peer-reviewed journal
-
- Letter of support from the respective head of the candidate’s current institution, incl. guarantee to provide sufficient research time for the project.
Submissions
Please send your application until March 31st, 2025.
Applications must be submitted electronically via SAKK, events@sakk.ch
For further information please refer to the documents below.
In collaboration with